Autopsy report · NCT02949375

Trial to Examine the Effect of Two Doses of GRI-0621 in Patients With Chronic Liver Disease

“Administrative decision”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 1 month after it had already started.
• Ran for about 3 years 9 months before it stopped.
• 14 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

GRI Bio Operations, Inc.

Sponsor type

Industry

Conditions

Chronic Liver Disease

Interventions

Placebo Comparator; Active Comparator:4.5mg GRI-0621; Active Comparator: 6.0mg GRI-0621

Participants

14

Sites

1

Countries

South Africa

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.